Reading the tealeaves, again, from the annual...

Reading the tealeaves, again, from the annual report

Additionally, the Directors continue to monitor expenditure against budget and are exploring other options should the cashflows be materially different to those forecast. In the event of a product launch which may be delayed, the Company could implement cash management strategies which could include:
— Deferral of current year project development expenditure;
— Management of operating expenses; or
— Monetisation of assets, such as actioning advance receipt of research and development tax incentive rebate or other revenue streams.

Negative cash flow of $8.8M or so in 2022. So, this maybe buys us another nine months of operations, something like that? All numbers are very rough and quite possibly just misunderstood. Just hoping someone else does the sums and corrects me.